These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 17452979)

  • 1. An osteopontin fragment is essential for tumor cell invasion in hepatocellular carcinoma.
    Takafuji V; Forgues M; Unsworth E; Goldsmith P; Wang XW
    Oncogene; 2007 Sep; 26(44):6361-71. PubMed ID: 17452979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteopontin promotes hepatocellular carcinoma invasion by up-regulating MMP-2 and uPA expression.
    Chen RX; Xia YH; Xue TC; Ye SL
    Mol Biol Rep; 2011 Aug; 38(6):3671-7. PubMed ID: 21104439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.
    Pan HW; Ou YH; Peng SY; Liu SH; Lai PL; Lee PH; Sheu JC; Chen CL; Hsu HC
    Cancer; 2003 Jul; 98(1):119-27. PubMed ID: 12833464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interference of osteopontin expression inhibits the invasion and metastasis of human hepatocellular carcinoma cell lines].
    Lin F; Li YY; Xia JT; Wen MJ; Lai YY; Cai WS; Wu ZF; Fan SF
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):422-5. PubMed ID: 19567019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thirty-kilodalton Tat-interacting protein suppresses tumor metastasis by inhibition of osteopontin transcription in human hepatocellular carcinoma.
    Zhao J; Lu B; Xu H; Tong X; Wu G; Zhang X; Liang A; Cong W; Dai J; Wang H; Wu M; Guo Y
    Hepatology; 2008 Jul; 48(1):265-75. PubMed ID: 18537194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma.
    Sun BS; Dong QZ; Ye QH; Sun HJ; Jia HL; Zhu XQ; Liu DY; Chen J; Xue Q; Zhou HJ; Ren N; Qin LX
    Hepatology; 2008 Dec; 48(6):1834-42. PubMed ID: 18972404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Green tea component epigallocatechin-3-gallate decreases expression of osteopontin via a decrease in mRNA half-life in cell lines of metastatic hepatocellular carcinoma.
    Zapf MA; Kothari AN; Weber CE; Arffa ML; Wai PY; Driver J; Gupta GN; Kuo PC; Mi Z
    Surgery; 2015 Oct; 158(4):1039-47; discussion 1047-8. PubMed ID: 26189955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human macrophages promote the motility and invasiveness of osteopontin-knockdown tumor cells.
    Cheng J; Huo DH; Kuang DM; Yang J; Zheng L; Zhuang SM
    Cancer Res; 2007 Jun; 67(11):5141-7. PubMed ID: 17545592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of osteopontin inhibits metastasis of hepatocellular carcinoma cells via a mechanism involving MMP-2 and uPA.
    Chen RX; Xia YH; Xue TC; Zhang H; Ye SL
    Oncol Rep; 2011 Mar; 25(3):803-8. PubMed ID: 21174062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of osteopontin and CD44s expression for patients with hepatocellular carcinoma undergoing liver transplantation or resection.
    Beckebaum S; Chen X; Sotiropoulos GC; Radtke A; Daoudaki M; Baba HA; Wohlschlaeger J; Broelsch CE; Gerken G; Cicinnati VR
    Transplant Proc; 2008 Nov; 40(9):3182-4. PubMed ID: 19010227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ELK3 promotes the migration and invasion of liver cancer stem cells by targeting HIF-1α.
    Lee JH; Hur W; Hong SW; Kim JH; Kim SM; Lee EB; Yoon SK
    Oncol Rep; 2017 Feb; 37(2):813-822. PubMed ID: 27959451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin is a therapeutic target for metastatic osteopontin-positive hepatocellular carcinoma.
    Xue YH; Zhang XF; Dong QZ; Sun J; Dai C; Zhou HJ; Ren N; Jia HL; Ye QH; Qin LX
    Hepatology; 2010 Dec; 52(6):2012-22. PubMed ID: 20890897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic stellate cells activated by acidic tumor microenvironment promote the metastasis of hepatocellular carcinoma via osteopontin.
    Song J; Ge Z; Yang X; Luo Q; Wang C; You H; Ge T; Deng Y; Lin H; Cui Y; Chu W; Yao M; Zhang Z; Gu J; Fan J; Qin W
    Cancer Lett; 2015 Jan; 356(2 Pt B):713-20. PubMed ID: 25449435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Knocking down osteopontin expression by specific siRNA reduces the in vitro invasiveness of human hepatocellular carcinoma cells].
    Zhu XQ; Ye QH; Lei KF; Chen J; Qin LX
    Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):404-7. PubMed ID: 17152482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Micro-RNA-181a regulates osteopontin-dependent metastatic function in hepatocellular cancer cell lines.
    Bhattacharya SD; Garrison J; Guo H; Mi Z; Markovic J; Kim VM; Kuo PC
    Surgery; 2010 Aug; 148(2):291-7. PubMed ID: 20576283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Identification of metastasis-related osteopontin expression and glycosylation in hepatocellular carcinoma].
    Sun HY; Li Y; Guo K; Kang XN; Sun C; Liu YK
    Zhonghua Gan Zang Bing Za Zhi; 2011 Dec; 19(12):904-7. PubMed ID: 22525502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteopontin as a key mediator for vasculogenic mimicry in hepatocellular carcinoma.
    Liu W; Xu G; Ma J; Jia W; Li J; Chen K; Wang W; Hao C; Wang Y; Wang X
    Tohoku J Exp Med; 2011 May; 224(1):29-39. PubMed ID: 21512310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteopontin splice variants differentially modulate the migratory activity of hepatocellular carcinoma cell lines.
    Chae S; Jun HO; Lee EG; Yang SJ; Lee DC; Jung JK; Park KC; Yeom YI; Kim KW
    Int J Oncol; 2009 Dec; 35(6):1409-16. PubMed ID: 19885563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation and prognostic value of osteopontin and Bcl-2 in hepatocellular carcinoma patients after curative resection.
    Deng B; Zhang XF; Zhu XC; Huang H; Jia HL; Ye QH; Dong QZ; Qin LX
    Oncol Rep; 2013 Dec; 30(6):2795-803. PubMed ID: 24065086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide-dependent osteopontin expression induces metastatic behavior in HepG2 cells.
    Guo H; Marroquin CE; Wai PY; Kuo PC
    Dig Dis Sci; 2005 Jul; 50(7):1288-98. PubMed ID: 16047475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.